MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy

被引：223
|
作者：
Ljungberg, Michael [1 ]
Celler, Anna [2 ]
Konijnenberg, Mark W. [3 ]
Eckerman, Keith F. [4 ]
Dewaraja, Yuni K. [5 ]
Sjogreen-Gleisner, Katarina
Bolch, Wesley E.
Brill, A. Bertrand
Fahey, Frederic
Fisher, Darrell R.
Hobbs, Robert
Howell, Roger W.
Meredith, Ruby F.
Sgouros, George
Zanzonico, Pat
Bacher, Klaus
Chiesa, Carlo
Flux, Glenn
Lassmann, Michael
Strigari, Lidia
Walrand, Stephan
机构：
[1] Lund Univ, Dept Med Radiat Phys, SE-22185 Lund, Sweden
[2] Univ British Columbia, Dept Radiol, Med Imaging Res Grp, Vancouver, BC, Canada
[3] Erasmus Univ, Med Ctr, Dept Nucl Med, Rotterdam, Netherlands
[4] Easterly Sci, Knoxville, TN USA
[5] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷 / 01期
基金：
瑞典研究理事会;
关键词：
image processing; oncology; endocrine; radiobiology/dosimetry; radionuclide therapy; SPECT/CT; guideline; lutetium; quantitative SPECT; RADIOLABELED SOMATOSTATIN ANALOG; RECEPTOR RADIONUCLIDE THERAPY; NEUROENDOCRINE TUMORS; INDIVIDUALIZED DOSIMETRY; 3-DIMENSIONAL DOSIMETRY; ACTIVITY QUANTIFICATION; MONOCLONAL-ANTIBODY; SCATTER CORRECTION; MEMBRANE ANTIGEN; DOSE ASSESSMENT;
D O I：
10.2967/jnumed.115.159012
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The accuracy of absorbed dose calculations in personalized internal radionuclide therapy is directly related to the accuracy of the activity (or activity concentration) estimates obtained at each of the imaging time points. MIRD Pamphlet no. 23 presented a general overview of methods that are required for quantitative SPECT imaging. The present document is next in a series of isotope-specific guidelines and recommendations that follow the general information that was provided in MIRD 23. This paper focuses on Lu-177 (lutetium) and its application in radiopharmaceutical therapy.
引用
收藏
页码：151 / 162
页数：12
相关论文
共 34 条
  • [21] Quantitative SPECT/CT Imaging of 177Lu with In Vivo Validation in Patients Undergoing Peptide Receptor Radionuclide Therapy
    Sanders, J. C.
    Kuwert, T.
    Hornegger, J.
    Ritt, P.
    MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (04) : 585 - 593
  • [22] Quantitative SPECT/CT Imaging of 177Lu with In Vivo Validation in Patients Undergoing Peptide Receptor Radionuclide Therapy
    J. C. Sanders
    T. Kuwert
    J. Hornegger
    P. Ritt
    Molecular Imaging and Biology, 2015, 17 : 585 - 593
  • [23] Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
    Grkovski, Milan
    O'Donoghue, Joseph A.
    Imber, Brandon S.
    Andl, George
    Tu, Cheng
    Lafontaine, Daniel
    Schwartz, Jazmin
    Thor, Maria
    Zelefsky, Michael J.
    Humm, John L.
    Bodei, Lisa
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1779 - 1787
  • [24] Improved prediction of haematological toxicity during [177Lu]Lu-DOTA-TATE therapy by optimising serial SPECT-CT red marrow dosimetry
    Tipping, J.
    Page, E.
    Calvert, N.
    Hamilton, D.
    Cullen, D.
    Price, E.
    Pells, S.
    Needham, G.
    Manoharan, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S239 - S239
  • [25] Technical note: Impact of dose voxel kernel (DVK) values on dosimetry estimates in 177Lu and 90Y radiopharmaceutical therapy (RPT) applications
    Danieli, Rachele
    Pistone, Daniele
    Tranel, Jonathan
    Botta, Francesca
    Uribe-Munoz, Carlos
    Raspanti, Davide
    Salvat, Francesc
    Wilderman, Scott J.
    Bardies, Manuel
    Amato, Ernesto
    Dewaraja, Yuni K.
    Cremonesi, Marta
    MEDICAL PHYSICS, 2024, 51 (01) : 522 - 532
  • [26] 2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
    Ken Herrmann
    Clemens Kratochwil
    Wolfgang P. Fendler
    Matthias Eiber
    Roland Hustinx
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2668 - 2669
  • [27] 2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? Reply to "A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands" by Dr. Germo Gericke
    Herrmann, Ken
    Kratochwil, Clemens
    Fendler, Wolfgang P.
    Eiber, Matthias
    Hustinx, Roland
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (09) : 2668 - 2669
  • [28] Evaluation of Template-based Partial Volume Correction Methods in 177Lu SPECT imaging for Dosimetry Improvement in Peptide Receptor Radionuclide Therapy
    Brolin, G.
    Gustafsson, J.
    Gleisner, K. Sjogreen
    Ljungberg, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S311 - S311
  • [29] Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
    Astrid Delker
    Mirjam Schleske
    Grigory Liubchenko
    Isabella Berg
    Mathias Johannes Zacherl
    Matthias Brendel
    Franz Josef Gildehaus
    Mikhail Rumiantcev
    Sandra Resch
    Kerstin Hürkamp
    Vera Wenter
    Lena M. Unterrainer
    Peter Bartenstein
    Sibylle I. Ziegler
    Leonie Beyer
    Guido Böning
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1280 - 1290
  • [30] Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
    Delker, Astrid
    Schleske, Mirjam
    Liubchenko, Grigory
    Berg, Isabella
    Zacherl, Mathias Johannes
    Brendel, Matthias
    Gildehaus, Franz Josef
    Rumiantcev, Mikhail
    Resch, Sandra
    Huerkamp, Kerstin
    Wenter, Vera
    Unterrainer, Lena M.
    Bartenstein, Peter
    Ziegler, Sibylle, I
    Beyer, Leonie
    Boening, Guido
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (05) : 1280 - 1290
1234